Quarterly report pursuant to Section 13 or 15(d)

FINANCING EXPENSES, NET

v3.21.2
FINANCING EXPENSES, NET
9 Months Ended
Sep. 30, 2021
FINANCING EXPENSES, NET

NOTE 6 - FINANCING EXPENSES, NET

    2021     2020     2021     2020  
   

Nine months period ended

September 30,

    Three months period ended
September 30,
 
    2021     2020     2021     2020  
    Unaudited     Unaudited     Unaudited     Unaudited  
                         
Modification of terms relating to straight loan transaction   $ 88     $ -     $ -     $ -  
Modification of terms relating to convertible bridge loans transactions     -       (3,495 )     -       (7,334 )
Exchange differences relating to loans from shareholders     -       40       -       (43 )
Issuance of ordinary shares and stock warrants upon modification of terms relating to convertible bridge loans transactions             415               415  
Issuance of shares as a settlement in excess of the carrying amount of financial liabilities     -       1,234       -      

734

 
Amortization of discounts and accrued interest on convertible bridge loans     18,080       8,393       4,432       10,896  
Amortization of discounts and accrued interest on straight loans     2,290       -       1,637       -  
Change in fair value of derivative warrants liability and fair value of warrants expired     (299 )     -       (5 )     -  
Change in fair value of liability related to conversion feature of convertible bridge loans     (3,777 )     -       530       -  
Issuance of shares as call options to acquire potential acquire     -       3,000       -       1,000  
Settlement in cash of prepayment obligation related to convertible bridge loan     182               182        
Interest and related royalties under receivables financing facility     546      

633

      495      

633

 
Amortization of prepaid expenses related to commitment shares in connection with receivables financing facility and equity line     293       61       293       -  
Exchange rate differences and other finance expenses     250     1,094       (689 )     754  
Financing (income) expenses, net   $ 17,360     $ 11,375     $ 6,875     $ 7,055  

 

 

TODOS MEDICAL LTD.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

(U.S. dollars in thousands)